150 participants
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-22
- Start Date:
- 2026-01-12
- Completion:
- 2031-07-31
Conditions
- Diabetes Mellitus, Type 1
Interventions
- DRUG
No Results Yet